An experimental HIV drug that has been used to successfully treat COVID-19 patients is in its second phase of testing with the Food and Drug Administration and could potentially be approved for use in four weeks, its manufacturer says.
Leronlimab, made by the biotech company CytoDyn, was used to treat a handful of severely ill patients in New York City hospitals; a couple were able to be removed from their ventilators.
“I think the FDA will be willing to work with us,” CytoDyn CEO Nader Pourhassan told The Post. “I am hoping it will be expedited … I don’t see how the FDA couldn’t approve it.”
“With a study in China indicating the mortality rate among COVID-19 patients requiring mechanical ventilators at more than 85 percent, the world desperately needs a therapy that can help this patient population,” Pourhassan added.
Initial studies suggest leronlimab can reduce the overactive immune response, known as a cytokine storm, that can be triggered by the coronavirus infection. Cytokine storms can result in pneumonia and even death.
JungleFever
Subscribe to:
Post Comments (Atom)
Featured Post
OMG : How My ‘Yahoo’ Son Tried To Remove My Eyes For Money Ritual
Delta Woman Emma Eregarnoma invited his mother, Mrs Oke Eregarnoma, to his house on Caroline Street, Okuokoko after he persuaded her that...
-
Phyna made history again with her win to become the second female BBNaija winner. Mercy Eke has congratulated Phyna for winning the BB...
-
It is a heartbreaking time for the Yoruba movie industry as they lose one of their colleague, Sisi Quadri.
-
A picture that resembles a buzzing comedian asking a lady to remove her pants publicly has been trending online. Alleged picture of ...
-
As the virus continues to spread around the world, the UK Government has now taken it upon it self to educate people and how the virus can...
-
Gov Seyi Makinde of Oyo State joined members of the Nigeria Labour Congress (NLC) in their protest against the economic hardship on Tuesda...
No comments:
Post a Comment